Introduction Semaglutide, a medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://raymondlquwz.wikinewspaper.com/3414480/semaglutide_a_game_changer_in_weight_loss_diabetes_and_heart_health